Valuation: Zalicus Inc

Market Cap 746K 654K 605K 556K 1.05M 71.96M 1.07M 7.23M 2.83M 35.21M 2.8M 2.74M 121M P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -15.94M -13.97M -12.91M -11.87M -22.4M -1.54B -22.76M -154M -60.52M -752M -59.84M -58.53M -2.59B EV / Sales 2014
14,770,294,750x
EV / Sales 2015 83,658,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-4.01%-0.84%+2.28% 49.18B
-3.10%-1.94%+370.99%+572.60% 39.58B
-0.46%+2.18%+5.44%+61.01% 34.69B
-1.14%-1.76%+26.94%-9.93% 34.42B
-1.82%-1.43%+0.52%+31.85% 27.11B
-3.54%-5.08% - - 16.21B
-1.82%-0.43%+69.28%+113.82% 15.36B
+1.17%+2.30%+15.87%+18.26% 14.05B
-2.25%+0.05%+15.77%-32.83% 13.02B
Average -1.49%-1.04%+63.00%+94.63% 27.07B
Weighted average by Cap. -1.43%-1.41%+75.91%+118.68%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.39 0.01 0.04 0.02 0.19 0.02 0.01 0.65 0.7 0.61 0.57 0.52 0.99 67.6 1 6.79 2.66 33.07 2.63 2.57 113.95
Net income -41.84M -36.68M -33.9M -31.18M -58.83M -4.04B -59.77M -405M -159M -1.97B -157M -154M -6.8B -52.19M -45.74M -42.28M -38.89M -73.37M -5.03B -74.55M -506M -198M -2.46B -196M -192M -8.48B
Net Debt -14.18M -12.43M -11.49M -10.57M -19.94M -1.37B -20.26M -137M -53.85M -669M -53.25M -52.08M -2.31B -16.68M -14.62M -13.52M -12.43M -23.45M -1.61B -23.83M -162M -63.35M -787M -62.64M -61.27M -2.71B
Logo Zalicus Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-